The Current Evidence for the Use of Safinamide for the Treatment of Parkinson’s Disease
Giovanni Abbruzzese,1 Paolo Barone,2 Leonardo Lopiano,3 Fabrizio Stocchi4 1Department of Neuroscience, University of Genova, Genova, Italy; 2School of Medicine, University of Salerno, Salerno, Italy; 3Department of Neuroscience, University of Turin, AOU Città della Salute e della Scienza,...
Main Authors: | Abbruzzese G, Barone P, Lopiano L, Stocchi F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-current-evidence-for-the-use-of-safinamide-for-the-treatment-of-pa-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence
by: Bette S, et al.
Published: (2018-09-01) -
Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
by: Stocchi F, et al.
Published: (2016-02-01) -
Safinamide: an add-on treatment for managing Parkinson’s disease
by: Müller T
Published: (2018-04-01) -
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
by: Ana Gómez-López, et al.
Published: (2021-01-01) -
Emerging approaches in Parkinson’s disease – adjunctive role of safinamide
by: Müller T
Published: (2016-08-01)